Pelton Matt, Ciarletta Matt, Wisnousky Holly, Lazzara Nicholas, Manglani Monica, Ba Djibril M, Chinchillli Vernon M, Du Ping, Ssentongo Anna E, Ssentongo Paddy
Department of Public Health Sciences, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Department of Surgery, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Gen Psychiatr. 2021 Apr 9;34(2):e100247. doi: 10.1136/gpsych-2020-100247. eCollection 2021.
People living with HIV/AIDS (PLWHA) must contend with a significant burden of disease. However, current studies of this demographic have yielded wide variations in the incidence of suicidality (defined as suicidal ideation, suicide attempt and suicide deaths).
This systematic review and meta-analysis aimed to assess the lifetime incidence and prevalence of suicidality in PLWHA.
Publications were identified from PubMed (MEDLINE), SCOPUS, OVID (MEDLINE), Joanna Briggs Institute EBP and Cochrane Library databases (from inception to before 1 February 2020). The search strategy included a combination of Medical Subject Headings associated with suicide and HIV. Researchers independently screened records, extracted outcome measures and assessed study quality. Data were pooled using a random-effects model. Subgroup and meta-regression analyses were conducted to explore the associated risk factors and to identify the sources of heterogeneity. Main outcomes were lifetime incidence of suicide completion and lifetime incidence and prevalence of suicidal ideation and suicide attempt.
A total of 185 199 PLWHA were identified from 40 studies (12 cohorts, 27 cross-sectional and 1 nested case-control). The overall incidence of suicide completion in PLWHA was 10.2/1000 persons (95%CI: 4.5 to 23.1), translating to 100-fold higher suicide deaths than the global general population rate of 0.11/1000 persons. The lifetime prevalence of suicide attempts was 158.3/1000 persons (95%CI: 106.9 to 228.2) and of suicidal ideation was 228.3/1000 persons (95%CI: 150.8 to 330.1). Meta-regression revealed that for every 10-percentage point increase in the proportion of people living with HIV with advanced disease (AIDS), the risk of suicide completion increased by 34 per 1000 persons. The quality of evidence by Grading of Recommendations, Assessment, Development and Evaluations for the suicide deaths was graded as 'moderate' quality.
The risk of suicide death is 100-fold higher in people living with HIV than in the general population. Lifetime incidence of suicidal ideation and attempts are substantially high. Suicide risk assessments should be a priority in PLWHA, especially for those with more advanced disease.
艾滋病毒/艾滋病感染者(PLWHA)必须应对重大的疾病负担。然而,目前针对这一人群的研究在自杀倾向(定义为自杀意念、自杀未遂和自杀死亡)发生率方面存在很大差异。
本系统评价和荟萃分析旨在评估艾滋病毒/艾滋病感染者自杀倾向的终生发病率和患病率。
从PubMed(MEDLINE)、SCOPUS、OVID(MEDLINE)、乔安娜·布里格斯循证医学研究所和考科蓝图书馆数据库(从建库至2020年2月1日前)中检索出版物。检索策略包括与自杀和艾滋病毒相关的医学主题词组合。研究人员独立筛选记录、提取结局指标并评估研究质量。采用随机效应模型汇总数据。进行亚组分析和元回归分析以探索相关危险因素并确定异质性来源。主要结局为自杀完成的终生发病率以及自杀意念和自杀未遂的终生发病率和患病率。
从40项研究(12项队列研究、2项横断面研究和1项巢式病例对照研究)中识别出总共185199名艾滋病毒/艾滋病感染者。艾滋病毒/艾滋病感染者自杀完成的总体发病率为10.2/1000人(95%置信区间:4.5至23.1),这意味着自杀死亡人数比全球普通人群0.11/1000人的比率高出100倍。自杀未遂的终生患病率为158.3/1000人(95%置信区间:106.9至228.2),自杀意念的终生患病率为228.3/1000人(95%置信区间:150.8至330.1)。元回归分析显示,晚期艾滋病毒感染者(艾滋病患者)比例每增加10个百分点,每1000人中自杀完成的风险就增加34例。根据推荐分级、评估、制定和评价系统对自杀死亡证据质量的分级为“中等”质量。
艾滋病毒感染者的自杀死亡风险比普通人群高100倍。自杀意念和自杀未遂的终生发病率相当高。自杀风险评估应成为艾滋病毒/艾滋病感染者的优先事项,尤其是对于那些疾病更严重的患者。